1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: Cancer J. Clin. 2011;61(2):69-90. [DOI:10.3322/caac.20107] [PMID]

2. Rezaeian M, Tabatabaei Z, Naeimi R, Esmaeili A, Jamali M, VaziriNejad R, Nouri E. Knowledge, attitude and practice of Rafsanjan male pensioners towards prevention of prostate cancer in the year 2006. HMS. 2007 Jan 10;12(4):19-25.

3. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991 Apr 25;324(17):1156-61.1991 Apr 25;324(17):1156-61. [DOI:10.1056/NEJM199104253241702] [PMID]

4. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 2013 Feb 1;63(2):234-41. [DOI:10.1016/j.eururo.2012.07.033] [PMID]

5. MOHAMMAD BA, Rezaeeianzadeh A, TABBATABAEI SH. Application of life table in survival analysis of patients with bladder cancer. ZJRMS. 2011 13(3), 25-29.

6. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine 18E Vol 2 EB. McGraw Hill Professional; 2012.

7. Makhdoumi, K H, Yekta Z, Ahmadpour P, Ghafari MA, Sadeghi N, Ghaderi P, Sadehdel M. One year graft survival: comparison between Azathioprin (AZA) and Mycophenolate Mofeti. UMJ. 2007 18(2), 474- 479.

8. Ponte B, Pruijm M, Ackermann D, Vuistiner P, Guessous I, Ehret G, Alwan H, Youhanna S, Paccaud F, Mohaupt M, Péchère-Bertschi A. Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study. J. Am. Soc. Nephrol. 2015 Jun 1;26(6):1415-25. [DOI:10.1681/ASN.2014030260] [PMID] [PMCID]

9. Kunin CM. Urinary tract infections and pyelonephritis. Cecil text book of medicine. 2000:613-7.

10. Barnett BJ, Stephens DS. Urinary tract infection: an overview. Am. J. Med. Sci. 1997 Oct 1;314(4):245-9. [DOI:10.1016/S0002-9629(15)40208-3]

11. Parsaei A, Kazemi SA, Samani S. Comparison of cognitive learning style high schools, and technical school students. Methods and mental models. 2011;2:47-64.

12. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney international. 2011 Dec 2;80(12):1258-70. [DOI:10.1038/ki.2011.368] [PMID]

13. Bos D, Abara E, Parmar MS. Knowledge, attitudes, and practice patterns among healthcare providers in the prevention of recurrent kidney stones in Northern Ontario. Can. Urol. Assoc. J. 2014 Nov;8(11-12):E795. [DOI:10.5489/cuaj.1455] [PMID] [PMCID]

14. Binsaleh S, Habous M, Madbouly K. Knowledge, attitudes, and practice patterns of recurrent urinary stones prevention in Saudi Arabia. Urolithiasis. 2016; 44(2), 135-143.

15. Surcel CI, Sooriakumaran P, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Isbarn H, Ost P, Ploussard G, van den Bergh RC, van Oort IM. Members of Prostate Cancer Working Group of Young Academic Urologists Working Party; Members of Young Urologists Office of European Association of Urology. Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey. BJU Int. 2015 Apr;115(4):571-9. [DOI:10.1111/bju.12796] [PMID]

16. Kiyota H, Onodera S, Ohishi Y, Tsukamoto T, Matsumoto T. Questionnaire survey of Japanese urologists concerning the diagnosis and treatment of chronic prostatitis and chronic pelvic pain syndrome. Int. J. Urol. 2003 Dec;10(12):636-42. [DOI:10.1046/j.1442-2042.2003.00720.x] [PMID]

17. Jalali, S, Bagheri Amiri F, Taheri M, Tavasoli S. Knowledge, attitude and practice in the prevention of kidney stones among Iranian urologists. Tehran- Univ-Med-J. 2020 77(11), 701-706.

18. Soleimani M, Masoumi N. Evaluating Urologists' Point Of View Regarding Common Though Debatable Matters. JNKUMS . 2017 Jan 10;8(3):523-34. [DOI:10.18869/acadpub.jnkums.8.3.523]